世界の線維素溶解療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Fibrinolytic Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2360
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、線維素溶解療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術治療、その他）、用途別市場規模（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル閉塞、急性虚血性脳卒中、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・線維素溶解療法の市場動向
・企業の競争状況、市場シェア
・線維素溶解療法の種類別市場規模（薬物治療、手術治療、その他）
・線維素溶解療法の用途別市場規模（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル閉塞、急性虚血性脳卒中、その他）
・線維素溶解療法の北米市場規模2016-2027（アメリカ、カナダ）
・線維素溶解療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・線維素溶解療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・線維素溶解療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・線維素溶解療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche、Boehringer Ingelheim、Mochida Pharmaceutical、NanJing Nanda Pharmaceutical、Wanhua Biochem、Tianjin Biochem Pharmaceutical、Livzon Pharmaceutical Group、Sedico Pharmaceuticals、Microbix、Syner-Med）
・結論

Market Analysis and Insights: Global Fibrinolytic Therapy Market
The global Fibrinolytic Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fibrinolytic Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fibrinolytic Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fibrinolytic Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fibrinolytic Therapy market.

Global Fibrinolytic Therapy Scope and Market Size
Fibrinolytic Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fibrinolytic Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Treatment
Surgical Treatment
Other Treatment

Segment by Application
Acute Myocardial Infarction
Pulmonary Embolism
Deep Vein Thrombosis
Blocking the Catheter
Acute Ischemic Stroke
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Boehringer Ingelheim
Mochida Pharmaceutical
NanJing Nanda Pharmaceutical
Wanhua Biochem
Tianjin Biochem Pharmaceutical
Livzon Pharmaceutical Group
Sedico Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibrinolytic Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Surgical Treatment
1.2.4 Other Treatment
1.3 Market by Application
1.3.1 Global Fibrinolytic Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Myocardial Infarction
1.3.3 Pulmonary Embolism
1.3.4 Deep Vein Thrombosis
1.3.5 Blocking the Catheter
1.3.6 Acute Ischemic Stroke
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Fibrinolytic Therapy Market Perspective (2016-2027)
2.2 Fibrinolytic Therapy Growth Trends by Regions
2.2.1 Fibrinolytic Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fibrinolytic Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Fibrinolytic Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Fibrinolytic Therapy Industry Dynamic
2.3.1 Fibrinolytic Therapy Market Trends
2.3.2 Fibrinolytic Therapy Market Drivers
2.3.3 Fibrinolytic Therapy Market Challenges
2.3.4 Fibrinolytic Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Fibrinolytic Therapy Players by Revenue
3.1.1 Global Top Fibrinolytic Therapy Players by Revenue (2016-2021)
3.1.2 Global Fibrinolytic Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Fibrinolytic Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fibrinolytic Therapy Revenue
3.4 Global Fibrinolytic Therapy Market Concentration Ratio
3.4.1 Global Fibrinolytic Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibrinolytic Therapy Revenue in 2020
3.5 Fibrinolytic Therapy Key Players Head office and Area Served
3.6 Key Players Fibrinolytic Therapy Product Solution and Service
3.7 Date of Enter into Fibrinolytic Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Fibrinolytic Therapy Breakdown Data by Type
4.1 Global Fibrinolytic Therapy Historic Market Size by Type (2016-2021)
4.2 Global Fibrinolytic Therapy Forecasted Market Size by Type (2022-2027)

5 Fibrinolytic Therapy Breakdown Data by Application
5.1 Global Fibrinolytic Therapy Historic Market Size by Application (2016-2021)
5.2 Global Fibrinolytic Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Fibrinolytic Therapy Market Size (2016-2027)
6.2 North America Fibrinolytic Therapy Market Size by Type
6.2.1 North America Fibrinolytic Therapy Market Size by Type (2016-2021)
6.2.2 North America Fibrinolytic Therapy Market Size by Type (2022-2027)
6.2.3 North America Fibrinolytic Therapy Market Size by Type (2016-2027)
6.3 North America Fibrinolytic Therapy Market Size by Application
6.3.1 North America Fibrinolytic Therapy Market Size by Application (2016-2021)
6.3.2 North America Fibrinolytic Therapy Market Size by Application (2022-2027)
6.3.3 North America Fibrinolytic Therapy Market Size by Application (2016-2027)
6.4 North America Fibrinolytic Therapy Market Size by Country
6.4.1 North America Fibrinolytic Therapy Market Size by Country (2016-2021)
6.4.2 North America Fibrinolytic Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Fibrinolytic Therapy Market Size (2016-2027)
7.2 Europe Fibrinolytic Therapy Market Size by Type
7.2.1 Europe Fibrinolytic Therapy Market Size by Type (2016-2021)
7.2.2 Europe Fibrinolytic Therapy Market Size by Type (2022-2027)
7.2.3 Europe Fibrinolytic Therapy Market Size by Type (2016-2027)
7.3 Europe Fibrinolytic Therapy Market Size by Application
7.3.1 Europe Fibrinolytic Therapy Market Size by Application (2016-2021)
7.3.2 Europe Fibrinolytic Therapy Market Size by Application (2022-2027)
7.3.3 Europe Fibrinolytic Therapy Market Size by Application (2016-2027)
7.4 Europe Fibrinolytic Therapy Market Size by Country
7.4.1 Europe Fibrinolytic Therapy Market Size by Country (2016-2021)
7.4.2 Europe Fibrinolytic Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Fibrinolytic Therapy Market Size (2016-2027)
8.2 Asia-Pacific Fibrinolytic Therapy Market Size by Type
8.2.1 Asia-Pacific Fibrinolytic Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fibrinolytic Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fibrinolytic Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Fibrinolytic Therapy Market Size by Application
8.3.1 Asia-Pacific Fibrinolytic Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fibrinolytic Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fibrinolytic Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Fibrinolytic Therapy Market Size by Region
8.4.1 Asia-Pacific Fibrinolytic Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fibrinolytic Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Fibrinolytic Therapy Market Size (2016-2027)
9.2 Latin America Fibrinolytic Therapy Market Size by Type
9.2.1 Latin America Fibrinolytic Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Fibrinolytic Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Fibrinolytic Therapy Market Size by Type (2016-2027)
9.3 Latin America Fibrinolytic Therapy Market Size by Application
9.3.1 Latin America Fibrinolytic Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Fibrinolytic Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Fibrinolytic Therapy Market Size by Application (2016-2027)
9.4 Latin America Fibrinolytic Therapy Market Size by Country
9.4.1 Latin America Fibrinolytic Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Fibrinolytic Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Fibrinolytic Therapy Market Size (2016-2027)
10.2 Middle East & Africa Fibrinolytic Therapy Market Size by Type
10.2.1 Middle East & Africa Fibrinolytic Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fibrinolytic Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fibrinolytic Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Fibrinolytic Therapy Market Size by Application
10.3.1 Middle East & Africa Fibrinolytic Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fibrinolytic Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fibrinolytic Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Fibrinolytic Therapy Market Size by Country
10.4.1 Middle East & Africa Fibrinolytic Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fibrinolytic Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Fibrinolytic Therapy Introduction
11.1.4 Roche Revenue in Fibrinolytic Therapy Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Fibrinolytic Therapy Introduction
11.2.4 Boehringer Ingelheim Revenue in Fibrinolytic Therapy Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Mochida Pharmaceutical
11.3.1 Mochida Pharmaceutical Company Details
11.3.2 Mochida Pharmaceutical Business Overview
11.3.3 Mochida Pharmaceutical Fibrinolytic Therapy Introduction
11.3.4 Mochida Pharmaceutical Revenue in Fibrinolytic Therapy Business (2016-2021)
11.3.5 Mochida Pharmaceutical Recent Development
11.4 NanJing Nanda Pharmaceutical
11.4.1 NanJing Nanda Pharmaceutical Company Details
11.4.2 NanJing Nanda Pharmaceutical Business Overview
11.4.3 NanJing Nanda Pharmaceutical Fibrinolytic Therapy Introduction
11.4.4 NanJing Nanda Pharmaceutical Revenue in Fibrinolytic Therapy Business (2016-2021)
11.4.5 NanJing Nanda Pharmaceutical Recent Development
11.5 Wanhua Biochem
11.5.1 Wanhua Biochem Company Details
11.5.2 Wanhua Biochem Business Overview
11.5.3 Wanhua Biochem Fibrinolytic Therapy Introduction
11.5.4 Wanhua Biochem Revenue in Fibrinolytic Therapy Business (2016-2021)
11.5.5 Wanhua Biochem Recent Development
11.6 Tianjin Biochem Pharmaceutical
11.6.1 Tianjin Biochem Pharmaceutical Company Details
11.6.2 Tianjin Biochem Pharmaceutical Business Overview
11.6.3 Tianjin Biochem Pharmaceutical Fibrinolytic Therapy Introduction
11.6.4 Tianjin Biochem Pharmaceutical Revenue in Fibrinolytic Therapy Business (2016-2021)
11.6.5 Tianjin Biochem Pharmaceutical Recent Development
11.7 Livzon Pharmaceutical Group
11.7.1 Livzon Pharmaceutical Group Company Details
11.7.2 Livzon Pharmaceutical Group Business Overview
11.7.3 Livzon Pharmaceutical Group Fibrinolytic Therapy Introduction
11.7.4 Livzon Pharmaceutical Group Revenue in Fibrinolytic Therapy Business (2016-2021)
11.7.5 Livzon Pharmaceutical Group Recent Development
11.8 Sedico Pharmaceuticals
11.8.1 Sedico Pharmaceuticals Company Details
11.8.2 Sedico Pharmaceuticals Business Overview
11.8.3 Sedico Pharmaceuticals Fibrinolytic Therapy Introduction
11.8.4 Sedico Pharmaceuticals Revenue in Fibrinolytic Therapy Business (2016-2021)
11.8.5 Sedico Pharmaceuticals Recent Development
11.9 Microbix
11.9.1 Microbix Company Details
11.9.2 Microbix Business Overview
11.9.3 Microbix Fibrinolytic Therapy Introduction
11.9.4 Microbix Revenue in Fibrinolytic Therapy Business (2016-2021)
11.9.5 Microbix Recent Development
11.10 Syner-Med
11.10.1 Syner-Med Company Details
11.10.2 Syner-Med Business Overview
11.10.3 Syner-Med Fibrinolytic Therapy Introduction
11.10.4 Syner-Med Revenue in Fibrinolytic Therapy Business (2016-2021)
11.10.5 Syner-Med Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fibrinolytic Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Key Players of Other Treatment
Table 5. Global Fibrinolytic Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Fibrinolytic Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Fibrinolytic Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Fibrinolytic Therapy Market Share by Regions (2016-2021)
Table 9. Global Fibrinolytic Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Fibrinolytic Therapy Market Share by Regions (2022-2027)
Table 11. Fibrinolytic Therapy Market Trends
Table 12. Fibrinolytic Therapy Market Drivers
Table 13. Fibrinolytic Therapy Market Challenges
Table 14. Fibrinolytic Therapy Market Restraints
Table 15. Global Fibrinolytic Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Fibrinolytic Therapy Market Share by Players (2016-2021)
Table 17. Global Top Fibrinolytic Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibrinolytic Therapy as of 2020)
Table 18. Ranking of Global Top Fibrinolytic Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Fibrinolytic Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Fibrinolytic Therapy Product Solution and Service
Table 22. Date of Enter into Fibrinolytic Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Fibrinolytic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Fibrinolytic Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Fibrinolytic Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Fibrinolytic Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Fibrinolytic Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Fibrinolytic Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Fibrinolytic Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Fibrinolytic Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Fibrinolytic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Fibrinolytic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Fibrinolytic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Fibrinolytic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Fibrinolytic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Fibrinolytic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Fibrinolytic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Fibrinolytic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Fibrinolytic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Fibrinolytic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Fibrinolytic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Fibrinolytic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Fibrinolytic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Fibrinolytic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Fibrinolytic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Fibrinolytic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Fibrinolytic Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Fibrinolytic Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Fibrinolytic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Fibrinolytic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Fibrinolytic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Fibrinolytic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Fibrinolytic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Fibrinolytic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Fibrinolytic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Fibrinolytic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Fibrinolytic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Fibrinolytic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Fibrinolytic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Fibrinolytic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Fibrinolytic Therapy Product
Table 65. Roche Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Fibrinolytic Therapy Product
Table 70. Boehringer Ingelheim Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Development
Table 72. Mochida Pharmaceutical Company Details
Table 73. Mochida Pharmaceutical Business Overview
Table 74. Mochida Pharmaceutical Fibrinolytic Therapy Product
Table 75. Mochida Pharmaceutical Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 76. Mochida Pharmaceutical Recent Development
Table 77. NanJing Nanda Pharmaceutical Company Details
Table 78. NanJing Nanda Pharmaceutical Business Overview
Table 79. NanJing Nanda Pharmaceutical Fibrinolytic Therapy Product
Table 80. NanJing Nanda Pharmaceutical Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 81. NanJing Nanda Pharmaceutical Recent Development
Table 82. Wanhua Biochem Company Details
Table 83. Wanhua Biochem Business Overview
Table 84. Wanhua Biochem Fibrinolytic Therapy Product
Table 85. Wanhua Biochem Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 86. Wanhua Biochem Recent Development
Table 87. Tianjin Biochem Pharmaceutical Company Details
Table 88. Tianjin Biochem Pharmaceutical Business Overview
Table 89. Tianjin Biochem Pharmaceutical Fibrinolytic Therapy Product
Table 90. Tianjin Biochem Pharmaceutical Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 91. Tianjin Biochem Pharmaceutical Recent Development
Table 92. Livzon Pharmaceutical Group Company Details
Table 93. Livzon Pharmaceutical Group Business Overview
Table 94. Livzon Pharmaceutical Group Fibrinolytic Therapy Product
Table 95. Livzon Pharmaceutical Group Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 96. Livzon Pharmaceutical Group Recent Development
Table 97. Sedico Pharmaceuticals Company Details
Table 98. Sedico Pharmaceuticals Business Overview
Table 99. Sedico Pharmaceuticals Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 100. Sedico Pharmaceuticals Recent Development
Table 101. Microbix Company Details
Table 102. Microbix Business Overview
Table 103. Microbix Fibrinolytic Therapy Product
Table 104. Microbix Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 105. Microbix Recent Development
Table 106. Syner-Med Company Details
Table 107. Syner-Med Business Overview
Table 108. Syner-Med Fibrinolytic Therapy Product
Table 109. Syner-Med Revenue in Fibrinolytic Therapy Business (2016-2021) & (US$ Million)
Table 110. Syner-Med Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibrinolytic Therapy Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Surgical Treatment Features
Figure 4. Other Treatment Features
Figure 5. Global Fibrinolytic Therapy Market Share by Application: 2020 VS 2027
Figure 6. Acute Myocardial Infarction Case Studies
Figure 7. Pulmonary Embolism Case Studies
Figure 8. Deep Vein Thrombosis Case Studies
Figure 9. Blocking the Catheter Case Studies
Figure 10. Acute Ischemic Stroke Case Studies
Figure 11. Other Case Studies
Figure 12. Fibrinolytic Therapy Report Years Considered
Figure 13. Global Fibrinolytic Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Fibrinolytic Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Fibrinolytic Therapy Market Share by Regions: 2020 VS 2027
Figure 16. Global Fibrinolytic Therapy Market Share by Regions (2022-2027)
Figure 17. Global Fibrinolytic Therapy Market Share by Players in 2020
Figure 18. Global Top Fibrinolytic Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibrinolytic Therapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Fibrinolytic Therapy Revenue in 2020
Figure 20. Global Fibrinolytic Therapy Revenue Market Share by Type (2016-2021)
Figure 21. Global Fibrinolytic Therapy Revenue Market Share by Type (2022-2027)
Figure 22. North America Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Fibrinolytic Therapy Market Share by Type (2016-2027)
Figure 24. North America Fibrinolytic Therapy Market Share by Application (2016-2027)
Figure 25. North America Fibrinolytic Therapy Market Share by Country (2016-2027)
Figure 26. United States Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Fibrinolytic Therapy Market Share by Type (2016-2027)
Figure 30. Europe Fibrinolytic Therapy Market Share by Application (2016-2027)
Figure 31. Europe Fibrinolytic Therapy Market Share by Country (2016-2027)
Figure 32. Germany Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Fibrinolytic Therapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Fibrinolytic Therapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Fibrinolytic Therapy Market Share by Region (2016-2027)
Figure 42. China Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Fibrinolytic Therapy Market Share by Type (2016-2027)
Figure 50. Latin America Fibrinolytic Therapy Market Share by Application (2016-2027)
Figure 51. Latin America Fibrinolytic Therapy Market Share by Country (2016-2027)
Figure 52. Mexico Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Fibrinolytic Therapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Fibrinolytic Therapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Fibrinolytic Therapy Market Share by Country (2016-2027)
Figure 58. Turkey Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Fibrinolytic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Roche Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 63. Mochida Pharmaceutical Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 64. NanJing Nanda Pharmaceutical Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 65. Wanhua Biochem Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 66. Tianjin Biochem Pharmaceutical Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 67. Livzon Pharmaceutical Group Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 68. Sedico Pharmaceuticals Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 69. Microbix Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 70. Syner-Med Revenue Growth Rate in Fibrinolytic Therapy Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の血栓溶解療法市場規模・現状・予測（2021年-2027年）

Global Thrombolytic Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5646 2021年4月 94Pages
QYResearch社発行の本調査資料では、血栓溶解療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術治療、その他治療）、用途別市場規模（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル閉塞、急性虚血性脳卒中）、主要地域別市場...

世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年）

Global Anti–vascular Endothelial Growth Factor Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0421 2021年4月 98Pages
QYResearch社発行の本調査資料では、抗血管内皮増殖因子（抗VEGF）療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抽出注入、プリチャージ注入）、用途別市場規模（黄斑変性症、眼浮腫、ブドウ膜炎、網膜静脈閉塞症）、主要地域別市場規模（...

世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年）

世界のTCR-T療法市場規模・現状・予測（2021年-2027年）

Global TCR-T Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5565 2021年4月 96Pages
QYResearch社発行の本調査資料では、TCR-T療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家、同種異系）、用途別市場規模（難治性再発黒色腫、滑膜肉腫、多発性骨髄腫、肺がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の膵臓がん治療市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cancer Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z4417 2021年4月 94Pages
QYResearch社発行の本調査資料では、膵臓がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物学、化学療法、標的療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の抗炎症療法市場規模・現状・予測（2021年-2027年）

Global Anti-inflammatory Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0396 2021年4月 90Pages
QYResearch社発行の本調査資料では、抗炎症療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗炎症生物製剤、非ステロイド性抗炎症薬、その他）、用途別市場規模（呼吸器疾患、関節炎、消化器内科、皮膚科、その他）、主要地...

世界の冷間性疼痛療法市場規模・現状・予測（2021年-2027年）

Global Cold Pain Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1436 2021年4月 125Pages
QYResearch社発行の本調査資料では、冷間性疼痛療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC製品、処方薬）、用途別市場規模（筋骨格系障害、スポーツ医学、術後療法、心的外傷後療法）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の治療用商品化小分子市場規模・現状・予測（2021年-2027年）

Global Commercialized Small Molecule for Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1485 2021年4月 91Pages
QYResearch社発行の本調査資料では、治療用商品化小分子のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（チロシン・セリン/スレオニンキナーゼ標的、プロテアソーム標的、MMP・HSP標的、アポトーシス標的）、用途別市場規模（治療、症状緩和）...

世界の不眠症治療市場規模・現状・予測（2021年-2027年）

Global Insomnia Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z3182 2021年4月 132Pages
QYResearch社発行の本調査資料では、不眠症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非薬物療法、薬物療法）、用途別市場規模（病院、外来手術センター、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のエステティック併用療法市場規模・現状・予測（2021年-2027年）

Global Aesthetics Combination Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0150 2021年4月 99Pages
QYResearch社発行の本調査資料では、エステティック併用療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BTx-A /皮膚充填剤、BTx-A /レーザー、レーザー/局所薬、レーザー/高周波、皮膚充填剤/局所薬、その他）、用途別市場規模...

世界の急性虚血性脳卒中診断・治療市場規模・現状・予測（2021年-2027年） According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Market Analysis and Insights: Global Acute Ischemic Stroke Diagnosis and Treatment Market The global Acute Ischemic Stroke Diagnosis and Treatment market size is projected…
世界の血栓溶解療法市場規模・現状・予測（2021年-2027年） The thrombolytic therapy market covers drug treatment, surgical treatment, etc. The typical players include Roche, Taj Pharmaceuticals, Genentech, etc. The global thrombolytic therapy market is dominated by companies from Switzerland, top three players occupy for over 62.78% market share in 2019. To…
世界の急性虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
世界の急性虚血性脳卒中治療市場規模・現状・予測（2021年-2027年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
世界の深部静脈血栓症（DVT）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…